In vitro, NAD+ supplementation of glomerular mesangial cells incubated with high glucose confirmed activation of the SIRT1 and AMPK pathways and protected the cells from hypertrophy, an early manifestation of diabetic nephropathy. Here, SIRT1 is linked to diabetic kidney disease.